ID
37646
Beskrivning
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Nyckelord
Versioner (1)
- 2019-08-13 2019-08-13 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
13 augusti 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Prior to Second Cycle
- StudyEvent: ODM
Beskrivning
Computed tomography
Alias
- UMLS CUI-1
- C0040405
Beskrivning
X-Ray Computed Tomography, Performed
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Beskrivning
X-Ray Computed Tomography, Changed status
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0443172
Beskrivning
X-Ray Computed Tomography, Finding
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0243095
Beskrivning
X-Ray Computed Tomography, Date in time
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0011008
Beskrivning
Assessment of response
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
Beskrivning
Response to treatment, Evaluation, Performed
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beskrivning
Response to treatment, Evaluation
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beskrivning
Response to treatment, Evaluation Method
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C2911685
Beskrivning
Response to treatment, Evaluation, Date in time
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0011008
Beskrivning
Response to treatment, Evaluation, Malignant Neoplasms
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0006826
Beskrivning
Serious adverse events
Alias
- UMLS CUI-1
- C1519255
Beskrivning
Status of the study
Alias
- UMLS CUI-1
- C0008976
- UMLS CUI-2
- C0449438
Similar models
Prior to Second Cycle
- StudyEvent: ODM
C0884358 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C2911685 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])